Romark Alinia Cryptosporidium Indication Expanded To Adults, Teens
This article was originally published in The Pink Sheet Daily
Supplement receives priority review at FDA; previous indication was in children ages one to 11 years. The firm is looking at future indications in Crohn’s disease and Clostridium difficile-associated diarrhea.
You may also be interested in...
Agency cites Millennium and Romark for misleading promotions.
The Irvine, Calif., firm also plans sNDAs for a colorectal cancer claim and an oral formulation of the leucovorin relative.